Physician profile
John B Chace
NPI 1043308059
$3,320.49
in general payments reported to CMS, 2019-2025
13 companies · $24.94 in 2025
The $24.94 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,079 · 2021: $25.93 · 2022: $44.37 · 2023: $993 · 2024: $153 · 2025: $24.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Travel and Lodging: $394 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.23 |
| Travel and Lodging | $394.30 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,644.42 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $167.41 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $137.61 | 2021-2025 | Phasix Mesh |
| Covidien LP | $87.66 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.21 | 2023 | Gattex |
| Innovation Technologies INC | $46.24 | 2023-2024 | Irrisept |
| Medtronic, INC. | $44.37 | 2022 | |
| Tas Medical, INC. | $33.54 | 2024 | |
| Abbvie INC. | $32.05 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Shockwave Medical, INC | $29.52 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pacira Pharmaceuticals Incorporated | $15.83 | 2024 | Exparel |
| Acell, INC. | $13.76 | 2019 | |
| W. L. Gore & Associates, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.